Leading Advanced Manufacturing Partner for Life Sciences

Speed to market is critical when your pipeline and patent timelines are at issue. An integrated design-build approach allows early alignment across design, engineering, procurement, and construction teams, reducing handoffs and minimizing rework. By sequencing the construction process to support commissioning, qualification, and validation, facilities can move more efficiently from concept to operational readiness.

Yes. Life sciences projects often include specialized lab space for quality control, R&D, and process development alongside production areas. Whether you are building pilot-scale environments or full-production suites, the facility must support experimentation and scalable operations within the same regulatory framework while maintaining strict safety standards.

Uncertainty is inherent in the life sciences industry. Facilities must be flexible enough to support multi-modal production, future equipment upgrades, and evolving regulatory expectations. Designing for adaptability without gross overbuild ensures your investment continues to support advanced manufacturing and future needs without requiring complete redevelopment as products or processes shift.

Commissioning, qualification, and validation activities must be considered early in the project lifecycle to support regulatory readiness and operational performance. Gray coordinates facility systems, clean utilities, process infrastructure, and construction sequencing to help streamline CQV activities as projects progress. By aligning teams early and reducing gaps between design, construction, and startup, we help support a more efficient path to operational readiness in regulated environments.

A well-designed life sciences facility does more than meet immediate production needs—it positions companies to capitalize on forthcoming FDA approvals and limited patent exclusivity. By planning for compliance, scalability, and future capacity from the outset, companies can launch faster, reduce their regulatory risk, and maximize revenue during their most profitable window, all while protecting long-term capital investment.

Look for a partner with a proven track record in delivering complex regulated environments where process integration, clean utilities, CQV coordination, and compliance documentation are central to success. These complex projects must be designed around the manufacturing process itself. A partner with relevant construction expertise understands how to coordinate all disciplines, anticipate regulatory expectations, and manage risk under collaborative delivery models like design-build and EPC. Experience in similar project types reduces risk and helps anticipate challenges before they impact the schedule or cost.

Facilities are the physical platforms that enable advanced research, regulated production, and commercial scale-up across medical, agricultural, industrial, and environmental applications. When properly designed and delivered, they support safe, compliant environments where teams can develop life-saving innovations, advance food and bio-based technologies, and bring new products to market with confidence.

Life sciences construction projects require close coordination across architecture, engineering, construction, and process integration from the earliest planning stages. When these disciplines operate independently, misalignment can delay validation, increase cost, and introduce compliance risk.

An integrated delivery model aligns facility engineering, design, construction, clean utilities, structural systems, and critical bioprocessing infrastructure around your manufacturing requirements from day one. By reducing handoffs and encouraging real-time collaboration, you gain greater cost and schedule certainty through overlapping scopes, coordinated CQV activities, and a more predictable path through commissioning, validation, and startup readiness.